Leukemia Research
Volume 26, Issue 8 , Pages 725-730, August 2002

FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies

Hematology Service, University Hospital La Fe, Valencia, Spain

Received 24 May 2001; received in revised form 16 November 2001; accepted 4 December 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(02)00003-6

Leukemia Research
Volume 26, Issue 8 , Pages 725-730, August 2002

Article Tools

* Image Usage & Resolution